Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 45.02 is 141% above its 4-year average of 18.72, near the high end of its 4-year range (0.00–45.02).
As of the fiscal period ended Tuesday, June 30, 2026. 89.55% above its 12-month average of 23.75.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 45.02.
QUICK RATIO (ACID-TEST)
45.02
QUICK RATIO (ACID-TEST) AVG TTM
23.75
QUICK RATIO (ACID-TEST) AVG 3Y
25.04
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+89.55%
CURRENT VS 3Y AVG
+79.79%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+1244.02%
vs the sector median at left
Sagimet Biosciences Inc.
Market Cap
$285.42M
Quick Ratio (Acid-Test)
45.02
TTM Avg
23.75
3Y Avg
25.04
5Y Avg
N/A
Market Cap
$285.38M
Quick Ratio (Acid-Test)
8.80
TTM Avg
4.55
3Y Avg
3.67
5Y Avg
2.92
Market Cap
$283.92M
Quick Ratio (Acid-Test)
2.80
TTM Avg
2.74
3Y Avg
2.22
5Y Avg
2.48
Market Cap
$286.40M
Quick Ratio (Acid-Test)
6.40
TTM Avg
6.41
3Y Avg
5.95
5Y Avg
4.92
Market Cap
$283.18M
Quick Ratio (Acid-Test)
4.69
TTM Avg
11.27
3Y Avg
11.27
5Y Avg
11.27
Market Cap
$281.92M
Quick Ratio (Acid-Test)
31.35
TTM Avg
25.02
3Y Avg
20.04
5Y Avg
16.05
Market Cap
$287.63M
Quick Ratio (Acid-Test)
19.48
TTM Avg
1.73
3Y Avg
4.11
5Y Avg
4.35
Market Cap
$291.71M
Quick Ratio (Acid-Test)
4.70
TTM Avg
5.10
3Y Avg
7.75
5Y Avg
8.34
Market Cap
$271.54M
Quick Ratio (Acid-Test)
4.97
TTM Avg
2.08
3Y Avg
1.48
5Y Avg
1.89
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sagimet Biosciences Inc. (SGMT) | $285.42M | 45.02 | 23.75 | 25.04 | N/A |
| Standard BioTools Inc. (LAB)vs › | $285.38M | 8.80 | 4.55 | 3.67 | 2.92 |
| Aurora Cannabis Inc. (ACB)vs › | $283.92M | 2.80 | 2.74 | 2.22 | 2.48 |
| Abeona Therapeutics Inc. (ABEO)vs › | $286.40M | 6.40 | 6.41 | 5.95 | 4.92 |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $283.18M | 4.69 | 11.27 | 11.27 | 11.27 |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.92M | 31.35 | 25.02 | 20.04 | 16.05 |
| Indaptus Therapeutics, Inc. (INDP)vs › | $287.63M | 19.48 | 1.73 | 4.11 | 4.35 |
| Larimar Therapeutics, Inc. (LRMR)vs › | $291.71M | 4.70 | 5.10 | 7.75 | 8.34 |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $271.54M | 4.97 | 2.08 | 1.48 | 1.89 |
| Scribe Therapeutics Inc. (SCTX)vs › | $272.34M | N/A | N/A | N/A | N/A |
Quick Ratio
45.02
Excludes inventory
Current Ratio
45.02
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 45.02 |
| 2026-03-31 | 20.34 |
| 2025-12-31 | 22.82 |
| 2025-09-30 | 13.04 |
| 2025-06-30 | 17.55 |
| 2025-03-31 | 20.34 |
| 2024-12-31 | 34.30 |
| 2024-09-30 | 38.41 |
| 2024-06-30 | 29.11 |
| 2024-03-31 | 43.12 |
| 2023-12-31 | 17.09 |
| 2023-09-30 | 20.36 |
| 2023-06-30 | 4.04 |
| 2023-03-31 | 5.12 |
| 2022-12-31 | 6.21 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
